Evidence map›Paper›PMID 33393103›Full record

ArticleAmerican journal of hematology2021

Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality.

Fien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Maria Magnusson, Nigel Mackman, Charlotte Thalin, Ton Lisman

Abstract readLetterComment
In one paragraph

Article in American journal of hematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Multi-factorial Mechanism Behind COVID-19 Related Thrombosis.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022
    Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Fien A von MeijenfeldtSurgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0003-0274-2414
Sebastian HavervallDivision of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
Jelle AdelmeijerSurgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Annika LundströmDivision of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
Maria MagnussonClinical Chemistry and Blood Coagulation Research, MMK, Dept of Pediatrics, CLINTEC, Karolinska Institutet, Dept. of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Nigel MackmanUNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Charlotte ThalinDivision of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
Ton LismanSurgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-3503-7140

Funding

Knut & Alice Wallenberg foundation. n/aRegion Stockholm
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Venous ThromboembolismFactor VHumansSARS-CoV-2Severity of Illness IndexFactor Vfactor V clotting antigen

Identifiers

PMID33393103
PMCPMC7986218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.